glp-1 receptor agonist common side effects Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of GLP-1 drugs: Illuminating their full

OBrien, A

Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations

Ameliorating effects of transcutaneous auricular vagus nerve stimulation on a mouse model of constipation-predominant irritable bowel syndrome

There are plenty of people who, if you try to get them down to a BMI of 25 or less, that will make them very frail and very, you know, predisposed to falling and breaking a hip or hurting themselves

Combined use in experimental designs may help characterize interactions between cytoprotective/vascular and structural-repair pathways

Oxidative stress also plays a role in sickle cell anemia, cystic fibrosis, and seizures